
Helper immune cells key to helping Pfizer's mRNA COVID-19 vaccine stave off death
As the world grapples with yet another variant of concern in the global COVID-19 pandemic, a new study shows how Pfizer-BioNTech's messenger RNA vaccine helps the immune system remember pathogens a | A type of helper immune cell is key to the Pfizer vaccine's delivery of a long-lasting punch...

Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine - Dec 31, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has completed...

A formal request for EUA should be happening in a month.